GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orient Pharma Co Ltd (ROCO:4166) » Definitions » Market Cap

Orient Pharma Co (ROCO:4166) Market Cap : NT$8,085 Mil (As of Mar. 29, 2025)


View and export this data going back to 2012. Start your Free Trial

What is Orient Pharma Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Orient Pharma Co's share price for the quarter that ended in Dec. 2024 was NT$35.9. Orient Pharma Co's Shares Outstanding (EOP) for the quarter that ended in Dec. 2024 was 224 Mil. Therefore, Orient Pharma Co's market cap for the quarter that ended in Dec. 2024 was NT$8,031 Mil.

Orient Pharma Co's quarterly market cap increased from Dec. 2023 (NT$4,427 Mil) to Jun. 2024 (NT$6,000 Mil) and increased from Jun. 2024 (NT$6,000 Mil) to Dec. 2024 (NT$8,031 Mil).

Orient Pharma Co's annual market cap increased from Dec. 2022 (NT$3,899 Mil) to Dec. 2023 (NT$4,427 Mil) and increased from Dec. 2023 (NT$4,427 Mil) to Dec. 2024 (NT$8,031 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Orient Pharma Co's Enterprise Value for Today is NT$8,523 Mil.


Orient Pharma Co Market Cap Historical Data

The historical data trend for Orient Pharma Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orient Pharma Co Market Cap Chart

Orient Pharma Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,721.04 3,459.56 3,899.01 4,427.24 8,030.69

Orient Pharma Co Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,899.01 5,575.88 4,427.24 5,999.64 8,030.69

Competitive Comparison of Orient Pharma Co's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Orient Pharma Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orient Pharma Co's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Orient Pharma Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Orient Pharma Co's Market Cap falls into.


;
;

Orient Pharma Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Orient Pharma Co's Market Cap for the fiscal year that ended in Dec. 2024 is calculated as

Market Cap (A: Dec. 2024 )=Share Price (A: Dec. 2024 )*Shares Outstanding (EOP) (A: Dec. 2024 )
=NT$35.9*223.696
=NT$8,031

Orient Pharma Co's Market Cap for the quarter that ended in Dec. 2024 is calculated as

Market Cap (Q: Dec. 2024 )=Share Price (Q: Dec. 2024 )*Shares Outstanding (EOP) (Q: Dec. 2024 )
=NT$35.9*223.696
=NT$8,031

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Orient Pharma Co  (ROCO:4166) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Orient Pharma Co Market Cap Related Terms

Thank you for viewing the detailed overview of Orient Pharma Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Orient Pharma Co Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Kehu 1st Road, Huwei Town, Yunlin County, Central Science Park, Taipei, TWN, 106
Orient Pharma Co Ltd develops and manufactures pharmaceuticals. The company uses its platform technologies for the development of specialty pharmaceutical products and is capable of manufacturing products under cGMP. It provides drugs for treating Alzheimer's disease, psychostimulants, and treating Parkinson's disease.

Orient Pharma Co Headlines

No Headlines